Catabasis Pharmaceuticals

Catabasis Pharmaceuticals

A pharmaceutical company engaged in the discovery and development of medicines for inflammatory conditions

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

November 14, 2013

Catabasis Pharmaceuticals raises a $32,400,000 series B round from MedImmune Ventures, Advanced Technology Ventures and Clarus Ventures.

December 2011

Catabasis Pharmaceuticals raises a $47,600,000 series A round from MedImmune Ventures and Advanced Technology Ventures.

December 8, 2010

Catabasis Pharmaceuticals raises a $14,500,000 series A round.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
4 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Elizabeth Adams

Employee

Keith Elliston

Employee

Lucy Xu

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.